Agence France-PresseApril 7, 2014 10:18
British drugmaker GlaxoSmithKline (GSK) is investigating alleged corruption by staff at its pharmaceuticals division in Iraq, the group announced on Monday.
GSK, which already faces a bribery probe in China, stressed that it would not tolerate illegal behaviour by staff.
"We are investigating allegations of improper conduct in our Iraq business. We have zero tolerance for unethical or illegal behaviour," a spokesman told AFP.